Fund+ Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
36
- Portfolio
-
15
- Exits
-
8
Fund+ General Information
Company Description
Founded in 2015, Fund+ is a venture capital firm based in Leuven, Belgium. The firm invests in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors in Belgium.
Business Details
Website
www.fundplus.beYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Groot Begijnhof 60
- 3000 Leuven
- Belgium
Fund+ Investments (36)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Confo Therapeutics | 26-Jul-2024 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 00000000 000 |
| Tubulis | 14-Mar-2024 | 00000 00000 | 00000 | Drug Discovery | Pre-Clinical Trials | 00000000 000 |
| AstriVax | 25-Aug-2022 | 0000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 00000000 000 |
| eTheRNA | 23-Aug-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 000000000 00 |
| Minoryx | 31-May-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000000 000 |
| NOVADIP | 24-May-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000000 000 |
| Tubulis | 03-May-2022 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 000 000 000 |
| TargED | 18-Feb-2022 | 00000 00000 | 000.00 | Drug Discovery | Pre-Clinical Trials | 000 000 000 |
| Cellaïon | 18-Jan-2022 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| EyeD Pharma | 22-Dec-2021 | Later Stage VC | 000.00 | Drug Discovery | Clinical Trials - Phase 1 | 00000 00000 |
Fund+ Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cardior | 25-Mar-2024 | Merger/Acquisition | 00.000 |
| Aelin Therapeutics | 07-Jul-2023 | 000 00 00000 | |
| Octimet Oncology | 01-Jan-2022 | 000000000 00 | |
| iTeos Therapeutics | 24-Jul-2020 | 000 | 00000 |
| Immunic Therapeutics | 12-Apr-2019 | 0000000 0000 | |
| Ogeda | 16-May-2017 | 000000000000 | 00000 |
| AmatsiQBiologicals | 25-Jan-2016 | Buyout/LBO | |
| Masthercell | 27-Feb-2015 | Merger/Acquisition | 000.00 |
Fund+ Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Fund+ Management, Team & Partners (9)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Bart De Leeuw | Partner & Chief Financial Officer | 0 | Leuven, Belgium | ||
| Halina Novak Ph.D | Principal | 0 | Leuven, Belgium |
Fund+ Co-Investors (104)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Société Régionale d'Investissement de Wallonie | 5 | 0 |
|
|
|
| LSP Management Group | 0 | 0 | 0 |
|
|
| V-Bio Ventures | 0 | 0 |
|
|
|
| Ackermans & van Haaren | 0 | 0 |
|
|
|
| Vives Fund | 0 | 0 |
|
|
Fund+ FAQs
-
What is Fund+?
Founded in 2015, Fund+ is a venture capital firm based in Leuven, Belgium.
-
When was Fund+ founded?
Fund+ was founded in 2015.
-
Where is Fund+ headquartered?
Fund+ is headquartered in Leuven, Belgium.
-
What is Fund+'s total asset value?
Fund+ has around 00000 in total assets under management.
-
How many investments has Fund+ made?
Fund+ has made 36 investments.
-
What has Fund+ invested in?
Fund+ has made numerous investments in companies like Confo Therapeutics, Tubulis, and AstriVax within the Drug Discovery industry.
-
What has Fund+ invested in recently?
Fund+'s latest investment was on 26-Jul-2024 in Confo Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
